Care & services Fertility & pregnancy Menopause Wellness Tech & devices

AI built for women, not just about women: Inside Ema’s groundbreaking pilot

By Published On: July 15, 2025
AI built for women, not just about women: Inside Ema’s groundbreaking pilot

By Morgan Rose, CNM, WHNP-BC, IBCLC | Chief Science Officer, Ema

AI is not a feature. It’s infrastructure.

That’s the thesis behind Ema’s newly launched Women’s Health AI Pilot, a fully funded programme aimed at rethinking how intelligence is integrated, not bolted on, across care, wellness, and diagnostics.

And it’s not hypothetical.

Five companies will be selected to co-design and deploy real use cases, powered by Ema’s clinically grounded, API-delivered AI platform.

The entire program is covered by Ema, underscoring their commitment to making thoughtful AI more accessible in women’s health.

The Opportunity

Applications are open through July 31, with five fully funded spots available. Ideal partners span:

  • Wellness brands scaling smarter support
  • Clinical platforms building triage or risk tools
  • FemTech products in fertility, postpartum, or menopause
  • Consumer health startups are ready to embed intelligence

What’s included:

  • Custom use case design with Ema’s clinical and product team
  • Full access to Ema’s AI API and design toolkit
  • Strategic spotlighting via co-authored content and press

Why This Matters

As Ema’s CEO, Amanda Ducach, puts it:

“We’re not here to add another chatbot. We’re building the layer of intelligence that makes women’s health tools actually work safely, smartly, and built for how care happens in real life.”

Unlike generic models, Ema operates from a curated, clinically validated knowledge base.

Her AI is conflict-checked, human-reviewed, and deployable anywhere a woman is making a health decision, whether on a postpartum website, within a fertility app, or while deciding whether to spend $599 on red light therapy for menopausal symptoms.

Built for the Real World

Ema’s infrastructure already powers tools like PatientsLikeMe, delivering not just conversations, but:

  • Behavioral data insights
  • Clinical flagging and assessment flows
  • Product fit engines and personalization
  • QA systems like “conflict meter” to align brand content with current medical standards

This pilot isn’t just a test; it’s a partnership.

The goal: to help forward-thinking teams integrate clinical-grade AI and give women the tools that meet them where they are, smart, respectful, and rooted in real life.

For more information on how to bring AI to life inside your product, apply here.

Apply by July 31

Interview: New horizons in endometriosis diagnosis
Research roundup: Overcoming EGFR-targeted therapy resistance in breast cancer, and more